Drawing for OWN YOUR FUTURE

USPTO serial 87713170

OWN YOUR FUTURE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
SCHMIDT, JOHN JOSEPH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OWN YOUR FUTURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Melissa A. Vallone

Melissa A. Vallone Barnes & Thornburg LLPP.O. Box 2786Chicago, IL 60690-2786UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035consulting services in the field of higher education administration, business management of educational research, business organization, business expansion, all provided to higher education institutions; business management consulting and business consulting in the healthcare industry; business consulting services and information services provided to organizations in the healthcare field in the areas of corporate governance, human resource management, business management, economics, performance improvement and business strategy and operations; business research services provided to organizations in the healthcare field in the areas of business management, economics and business strategy and operations; business consulting services to assist life sciences organizations and affiliates in the fields of business and program management and the pricing of goods and services according to fair market value determination in the healthcare, pharmaceutical and life science fields; business consultation in the fields of product distribution management and distribution channel management; business consulting services to assist hospitals, academic medical centers and independent research organizations with operational and organizational effectiveness in the field of clinical research and compliance with government regulations, policies and procedures; business consulting in the field of clinical trials, namely, compilation and analysis of data in the field of clinical trials for business purposes; business consulting services in the field of clinical research billing compliance; business and management consulting in the field of facilitating revenue enhancement, business and organizational alignment, supply chain management, operational improvement, post-merger integration, post-emergence management and selling, generalACTIVE
036consulting services provided to higher education institutions in the fields of financial management, budgeting and financial strategy; financial consulting services in the healthcare industry; real estate valuation services in the healthcare field; fair market value determination for fee for service activities, namely, financial valuation; cash management services in the healthcare industry; financial consulting services for forensic accounting, investigations and litigation; financial consulting services in the field of solutions to companies in transition, creditor constituencies, and other stakeholders in connection with out-of-court restructurings and bankruptcy proceedings; independent financial valuations and financial consulting services to assist clients in making informed decisions for transaction, tax or litigation purposesACTIVE
045regulatory compliance consulting services in the field of clinical trials to assist life sciences organizations and affiliates with aggregate spend disclosure reporting, corporate integrity agreements, Independent Review Organization procedures and Deferred Prosecution Agreements, and Government Price Reporting; consulting services, namely, providing independent review of clinical trials involving human subjects by reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research and compliance with clinical research governmental regulations; regulatory compliance consulting services, namely, assisting entities in implementing standards and protocols for complying with human research protection in clinical trials, and monitoring biomedical and behavioral research trials to ensure compliance with regulatory standardsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 8, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 8, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 27, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 25, 2020EX3GSOU EXTENSION 3 GRANTED
Jun 25, 2020EXT3SOU EXTENSION 3 FILED
Jun 25, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2019EX2GSOU EXTENSION 2 GRANTED
Dec 17, 2019EXT2SOU EXTENSION 2 FILED
Dec 17, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 23, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 7, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 2, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 8, 2019DOCKASSIGNED TO EXAMINER
Jun 22, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2019EX1GSOU EXTENSION 1 GRANTED
Jun 20, 2019EXT1SOU EXTENSION 1 FILED
Jun 20, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 3, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 27, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 27, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 20, 2018DOCKASSIGNED TO EXAMINER
Dec 19, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance